Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland)
PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000
26 Pages Posted: 2 Dec 2010
Date Written: December 1, 2010
Abstract
The paper discusses the scope of patents for medicines, and analyses which acts from third parties, ranging from clinical trials from competitors for improved medicines to generic manufacturers with me-too products, the patent holder can stop.
Note: Downloadable document is in Dutch.
Keywords: Patents, medicines, clinical trials, research exemption
JEL Classification: I18, K11, O32, O34, H51
Suggested Citation: Suggested Citation
Van Overwalle, Geertrui, Clinical Trials - The Situation in Belgium in the Light of Recent Case Law in the Netherlands and Germany (Proeven met geneesmiddelen - De situatie in België in het licht van de recente rechtspraak en rechtsleer in Nederland en Duitsland) (December 1, 2010). PATENT LAW AND MEDICINES, pp. 65-91, G. Van Overwalle, ed., Brussel, Bruylant, 2000, Available at SSRN: https://ssrn.com/abstract=1718624
Feedback
Feedback to SSRN
If you need immediate assistance, call 877-SSRNHelp (877 777 6435) in the United States, or +1 212 448 2500 outside of the United States, 8:30AM to 6:00PM U.S. Eastern, Monday - Friday.